Low-dose aspirin linked to increased anemia risk in elderly adults.
A retrospective analysis of the ASPREE trial showed that low-dose aspirin use can result in a 20% increase in anemia and a decrease in ferritin levels in older adults. The study suggests that hidden blood loss, not significant bleeding events, may be the primary cause. Older patients taking aspirin should be regularly monitored for hemoglobin levels.